ARVIND REMEDIES LTD.

NSE : NABSE : 531823ISIN CODE : INE211C01037Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.700 (0 %)
PREV CLOSE ( ) 4.70
OPEN PRICE ( ) 4.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2850
TODAY'S LOW / HIGH ( )4.70 4.70
52 WK LOW / HIGH ( ) 4.74.7
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2014Mar2013Mar2012Mar2011
Profit Before Tax890.50679.97402.65227.71
Adjustment879.95690.18293.78186.25
Changes In working Capital-2352.53-1098.17-575.24-222.59
Cash Flow after changes in Working Capital-582.08271.98121.19191.37
Cash Flow from Operating Activities-650.77128.7160.18120.96
Cash Flow from Investing Activities-246.39-1219.73-1581.98-618.71
Cash Flow from Financing Activities712.401107.251531.13554.83
Net Cash Inflow / Outflow-184.7516.249.3357.08
Opening Cash & Cash Equivalents242.67226.43207.86150.78
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANA9.24NA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANA
Effect of Foreign Exchange FluctuationsNANANANA
Closing Cash & Cash Equivalent57.92242.67226.43207.86

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.